B. C. Bozca Et Al. , "Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus," JOURNAL OF DERMATOLOGICAL TREATMENT , vol.33, no.4, pp.2102-2109, 2022
Bozca, B. C. Et Al. 2022. Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus. JOURNAL OF DERMATOLOGICAL TREATMENT , vol.33, no.4 , 2102-2109.
Bozca, B. C., BİLGİÇ, A., & UZUN, S., (2022). Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus. JOURNAL OF DERMATOLOGICAL TREATMENT , vol.33, no.4, 2102-2109.
Bozca, BURÇİN, ASLI BİLGİÇ, And SONER UZUN. "Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus," JOURNAL OF DERMATOLOGICAL TREATMENT , vol.33, no.4, 2102-2109, 2022
Bozca, BURÇİN C. Et Al. "Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus." JOURNAL OF DERMATOLOGICAL TREATMENT , vol.33, no.4, pp.2102-2109, 2022
Bozca, B. C. BİLGİÇ, A. And UZUN, S. (2022) . "Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus." JOURNAL OF DERMATOLOGICAL TREATMENT , vol.33, no.4, pp.2102-2109.
@article{article, author={BURÇİN CANSU BOZCA Et Al. }, title={Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus}, journal={JOURNAL OF DERMATOLOGICAL TREATMENT}, year=2022, pages={2102-2109} }